TTOO - T2 Biosystems Inc
IEX Last Trade
3.2
-0.200 -6.250%
Share volume: 164,241
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.40
-0.20
-5.88%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-16 | 2022-11-14 | 2023-03-31 | 2023-05-22 | 2023-08-08 | 2023-11-15 | 2024-04-01 | 2024-05-06 | |
| Assets | |||||||||
| Total Assets | 39.605 M | 43.952 M | 34.327 M | 32.732 M | 37.130 M | 43.281 M | 34.797 M | 24.755 M | |
| Current Assets | 24.702 M | 28.876 M | 19.359 M | 18.925 M | 23.870 M | 32.876 M | 25.189 M | 15.560 M | |
| Inventories | 5.673 M | 4.242 M | 4.285 M | 4.936 M | 4.337 M | 4.281 M | 4.819 M | 4.670 M | |
| Other Current Assets | 3.096 M | 2.690 M | 2.582 M | 2.549 M | 2.100 M | 3.137 M | 3.261 M | 3.094 M | |
| Short Term Investments | 3.096 M | 2.690 M | 2.582 M | 2.549 M | 2.100 M | 3.137 M | 3.261 M | 3.094 M | |
| Total Receivables | 2.721 M | 1.578 M | 2.163 M | 1.323 M | 1.349 M | 1.139 M | 1.420 M | 1.588 M | |
| Current Cash | 13.212 M | 20.366 M | 10.329 M | 10.117 M | 16.084 M | 24.319 M | 15.689 M | 6.208 M | |
| Total Non-current Assets | 14.903 M | 15.076 M | 14.968 M | 13.807 M | 13.260 M | 10.405 M | 9.608 M | 9.195 M | |
| Property Plant Equipment | 4.447 M | 4.734 M | 4.533 M | 4.801 M | 4.572 M | 2.042 M | 1.658 M | 1.611 M | |
| Other Assets | 9.325 M | 9.211 M | 8.884 M | 8.455 M | 8.137 M | 7.812 M | 7.399 M | 7.033 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 39.605 M | 43.952 M | 34.327 M | 32.732 M | 37.130 M | 43.281 M | 34.797 M | 24.755 M | |
| Total liabilities | 77.124 M | 75.291 M | 73.982 M | 82.618 M | 73.553 M | 62.517 M | 62.833 M | 62.528 M | |
| Total current liabilities | 13.192 M | 10.943 M | 10.128 M | 17.829 M | 66.056 M | 55.455 M | 56.152 M | 56.256 M | |
| Accounts Payable | 5.231 M | 2.063 M | 1.296 M | 3.131 M | 2.234 M | 1.088 M | 1.527 M | 1.887 M | |
| Other liabilities | 6.472 M | 6.591 M | 5.989 M | 6.849 M | 64.000 K | 40.000 K | 83.000 K | 92.000 K | |
| Current long term debt | 0.000 | 0.000 | 1.352 M | 1.415 M | 52.051 M | 47.317 M | 47.707 M | 48.084 M | |
| Long term debt | 57.460 M | 57.757 M | 57.865 M | 57.940 M | 7.433 M | 7.022 M | 6.598 M | 6.180 M | |
| Other liabilities | 6.472 M | 6.591 M | 5.989 M | 6.849 M | 64.000 K | 40.000 K | 83.000 K | 92.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -37.519 M | -31.339 M | -39.655 M | -49.886 M | -36.423 M | -19.236 M | -28.036 M | -37.773 M | |
| Common stock | 35.358 K | 60.088 K | 74.599 K | 136.334 K | 809.169 K | 4.477 M | 5.017 M | 5.095 M | |
| Retained earnings | -506.745 M | -524.120 M | -534.219 M | -552.184 M | -558.531 M | -573.956 M | -584.296 M | -597.830 M |